Wolters Kluwer 2022 Nine-Month Trading Update
Wolters Kluwer released its 2022 Nine-Month Trading Update on November 2, 2022, reporting a 6% organic revenue growth for the first nine months. Total revenues increased by 15% due to favorable currency effects. Recurring revenues contributed significantly, growing 7% organically. The company maintained its 2022 full-year guidance, with anticipated adjusted free cash flow between €1,025 and €1,075 million. Noteworthy developments include significant share buyback plans and acquisitions, including the purchase of IJS Publishing Group. However, adjusted free cash flow decreased 1% year-on-year.
- Full-year 2022 guidance reiterated.
- Nine-month revenues up 6% organically.
- Recurring revenues (81%) up 7% organically.
- Adjusted operating profit increased 6% in constant currencies.
- Share buyback program approx. 76% completed; on track to reach €1 billion.
- Adjusted free cash flow down 1% in constant currencies.
- Total print revenues declined 4% organically.
- Corporate costs increased by 10%, impacting margins.
Wolters Kluwer 2022 Nine-Month Trading Update
November 2, 2022 – Wolters Kluwer (EURONEXT: WKL), a global leader in professional information, software solutions and services, today releases its scheduled 2022 nine-month trading update.
Highlights
- Full-year 2022 guidance reiterated.
- Nine-month revenues up
6% organically.- Recurring revenues (
81% of total revenues) up7% organically; non-recurring revenues up4% . - Digital & services revenues (
93% of total revenues) up7% organically; print declined4% . - Expert solutions revenues (
56% of total) up9% organically.
- Recurring revenues (
- Nine-month adjusted operating profit up
6% in constant currencies.- Nine-month adjusted operating profit margin up 50 basis points.
- Nine-month adjusted free cash flow down
1% in constant currencies. - Net-debt-to-EBITDA ratio 1.3x as of September 30, 2022.
- Share buyback 2022: approx.
76% completed to date; on track to reach€1 billion by year-end. - Share buyback 2023: mandate signed to repurchase up to
€100 million in January and February 2023.
Nancy McKinstry, CEO and Chair of the Executive Board, commented: “Through the first nine months of the year, we have seen sustained strong organic growth in recurring revenues, led by our expert solutions. As expected, organic growth in transactional and other non-recurring revenues slowed in the face of challenging comparables and deteriorating economic conditions. We are investing at high levels in product innovation and in our talented workforce, and I am confident in reiterating our outlook for the full year.”
Nine Months to September 30, 2022
Total revenues increased
Recurring revenues (
Revenues from North America (
Nine-month adjusted operating profit increased
Health: Nine-month revenues increased
Tax & Accounting: Nine-month revenues increased
Governance, Risk & Compliance: Nine-month revenues increased
Legal & Regulatory: Nine-month revenues increased
Corporate costs increased
Cash Flow and Net Debt
Nine-month adjusted operating cash flow was flat in constant currencies due to lower cash conversion (
Total cash dividends paid to shareholders amounted to
As of September 30, 2022, net debt stood at
ESG Developments
In the year to date, we have made progress on several ESG objectives. In September, we launched our annual all-employee compliance training, covering IT and cybersecurity, data privacy, and business ethics. As of the end of October,
Share Buyback Programs
Early in the year, we announced a 2022 share buyback program of
Looking ahead to 2023, we have this week signed a third-party mandate to execute up to
Assuming global economic conditions do not deteriorate substantially, we continue to believe this level of share buybacks leaves us with ample headroom to support our dividend plans, to sustain organic investment, and to make selective acquisitions. The share repurchases may be suspended, discontinued, or modified at any time. Third party mandates are governed by the limits of relevant laws and regulations (in particular Regulation (EU) 596/2014) and Wolters Kluwer’s Articles of Association. Repurchased shares are added to and held as treasury shares and are either cancelled or held to meet future obligations arising from share-based incentive plans. We remain committed to our anti-dilution policy which aims to offset the dilution caused by our annual incentive share issuance with share repurchases.
Share Cancellation 2022
On August 31, 2022, we cancelled 5.0 million shares that were held in treasury, as approved by shareholders at the AGM in April 2022. Following this cancellation, the number of issued ordinary shares is 257,516,153. As of September 30, 2022, 252.3 million shares were outstanding and 5.2 million shares were held in treasury.
Full-Year 2022 Outlook
We reiterate our full-year guidance as provided on August 3, 2022. See table below. Following clarification of new U.S. tax rules on the capitalization of research and development expenses, we now expect adjusted free cash flow in constant currencies to be near the top of our guided range. We continue to expect organic momentum to slow moderately in the fourth quarter, largely due to challenging comparables.
Full-Year 2022 Outlook | ||
Performance indicators | 2022 Guidance | 2021 Actual |
Adjusted operating profit margin* | | |
Adjusted free cash flow | | |
ROIC* | | |
Diluted adjusted EPS growth | Mid- to high-single-digit growth | |
*Guidance for adjusted operating profit margin and ROIC is in reporting currency and assumes an average EUR/USD rate in 2022 of €/ |
If current exchange rates persist, the U.S. dollar rate will have a positive effect on 2022 results reported in euros. In 2021, Wolters Kluwer generated more than
We include restructuring costs in adjusted operating profit. We continue to expect that restructuring costs will be within our normal range of
We now expect the benchmark tax rate on adjusted pre-tax profits to be at the lower end of our guided range of
Our guidance assumes no additional significant change to the scope of operations. We may make further acquisitions or disposals which can be dilutive to margins, earnings, and ROIC in the near term.
2022 Outlook by Division
Health: we continue to expect organic growth to slow from 2021 levels (mainly due to the absence of a contract win of the size of the 2021 ASCO deal) and the adjusted operating profit margin to improve.
Tax & Accounting: we continue to expect organic growth to accelerate from 2021 levels and the adjusted operating profit margin to improve.
Governance, Risk & Compliance: we continue to expect organic growth to slow from 2021 levels, mainly due to an expected decline in transactional revenues in the second half. We expect the adjusted operating profit margin to improve for the full year.
Legal & Regulatory: we continue to expect organic growth to improve on 2021 levels. We expect the full-year adjusted operating profit margin to decline modestly due mainly to the absence of a one-off pension amendment recorded in 2021.
About Wolters Kluwer
Wolters Kluwer (EURONEXT: WKL) is a global leader in professional information, software solutions, and services for the healthcare; tax and accounting; governance, risk and compliance; and legal and regulatory sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with technology and services.
Wolters Kluwer reported 2021 annual revenues of
Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt (ADR) program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).
For more information, visit www.wolterskluwer.com, follow us on Twitter, Facebook, LinkedIn, and YouTube.
Financial Calendar
February 22, 2023 Full-Year 2022 Results
March 8, 2023 Publication of 2022 Annual Report
May 3, 2023 First-Quarter 2023 Trading Update
May 10, 2023 Annual General Meeting of Shareholders
May 12, 2023 Ex-dividend date: 2022 final dividend
May 15, 2023 Record date: 2022 final dividend
June 6, 2023 Payment date: 2022 final dividend ordinary shares
June 13, 2023 Payment date: 2022 final dividend ADRs
August 2, 2023 Half-Year 2023 Results
August 29, 2023 Ex-dividend date: 2023 interim dividend
August 30, 2023 Record date: 2023 interim dividend
September 21, 2023 Payment date: 2023 interim dividend
September 28, 2023 Payment date: 2023 interim dividend ADRs
November 1, 2023 Nine-Month 2023 Trading Update
Media | Investors/Analysts |
Gerbert van Genderen Stort | Meg Geldens |
Corporate Communications | Investor Relations |
t +31 172 641 230 | t +31 172 641 407 |
press@wolterskluwer.com | ir@wolterskluwer.com |
Forward-looking Statements and Other Important Legal Information
This report contains forward-looking statements. These statements may be identified by words such as “expect”, “should”, “could”, “shall” and similar expressions. Wolters Kluwer cautions that such forward-looking statements are qualified by certain risks and uncertainties that could cause actual results and events to differ materially from what is contemplated by the forward-looking statements. Factors which could cause actual results to differ from these forward-looking statements may include, without limitation, general economic conditions; conditions in the markets in which Wolters Kluwer is engaged; conditions created by global pandemics, such as COVID-19; behavior of customers, suppliers, and competitors; technological developments; the implementation and execution of new ICT systems or outsourcing; and legal, tax, and regulatory rules affecting Wolters Kluwer’s businesses, as well as risks related to mergers, acquisitions, and divestments. In addition, financial risks such as currency movements, interest rate fluctuations, liquidity, and credit risks could influence future results. The foregoing list of factors should not be construed as exhaustive. Wolters Kluwer disclaims any intention or obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Elements of this press release contain or may contain inside information about Wolters Kluwer within the meaning of Article 7(1) of the Market Abuse Regulation (596/2014/EU).
Trademarks referenced are owned by Wolters Kluwer N.V. and its subsidiaries and may be registered in various countries.
1 PPP = U.S. Paycheck Protection Program of 2020 and 2021. GRC’s Compliance Solutions supported banks in lending under this program.
2 EHS/ORM = environmental, health & safety and operational risk management.
3 Belonging measures the extent to which employees believe they can bring their authentic selves to work and be accepted for who they are. Belonging and engagement scores are measured by a third party (Microsoft GLINT).
4 This rule of thumb excludes the impact of exchange rate movements on intercompany balances, which is accounted for in adjusted net financing costs in reported currencies and determined based on period-end spot rates and balances.
5 Adjusted net financing costs include lease interest charges. Guidance for adjusted net financing costs in constant currencies excludes the impact of exchange rate movements on currency hedging and intercompany balances.
Attachment
FAQ
What were Wolters Kluwer's revenue growth highlights for 2022?
What is the outlook for Wolters Kluwer's adjusted free cash flow in 2022?
How much of the share buyback program has been completed?
What impact did currency fluctuations have on Wolters Kluwer's earnings?